These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Treatment of hairy-cell leukemia: current views. Tallman MS; Peterson LC; Hakimian D; Gillis S; Polliack A Semin Hematol; 1999 Apr; 36(2):155-63. PubMed ID: 10319384 [TBL] [Abstract][Full Text] [Related]
14. Minimal residual disease in hairy-cell leukemia after treatment with 2-chlorodeoxyadenosine. Konwalinka G; Schirmer M; Hilbe W; Fend F; Geisen F; Knoblechner A; Petzer A; Thaler J Blood Cells Mol Dis; 1995; 21(2):142-51. PubMed ID: 8846043 [TBL] [Abstract][Full Text] [Related]
15. Elevations in serum soluble interleukin-2 receptor levels predict relapse in patients with hairy cell leukemia. Arun B; Curti BD; Longo DL; Stevens D; Alvord WG; Gause BL; Watson T; Kopp WC; Janik JE Cancer J Sci Am; 2000; 6(1):21-4. PubMed ID: 10696734 [TBL] [Abstract][Full Text] [Related]
16. Minimal residual disease in patients with hairy cell leukemia in complete remission treated with 2-chlorodeoxyadenosine or 2-deoxycoformycin and prediction of early relapse. Tallman MS; Hakimian D; Kopecky KJ; Wheaton S; Wollins E; Foucar K; Cassileth PA; Habermann T; Grever M; Rowe JM; Peterson LC Clin Cancer Res; 1999 Jul; 5(7):1665-70. PubMed ID: 10430066 [TBL] [Abstract][Full Text] [Related]
17. Dyserythropoietic changes and sideroblastic anemia in patients with hairy cell leukemia before and after therapy with 2-chlorodeoxyadenosine. Zák P; Chrobák L; Podzimek K; Plísková L; Dedic K Neoplasma; 1998; 45(4):261-5. PubMed ID: 9890671 [TBL] [Abstract][Full Text] [Related]
18. Successful treatment of patients with hairy cell leukemia (HCL) using a single cycle of 2-chloro-2'-deoxyadenosine (CdA). Jehn U; Gawaz M; Grunewald R; Hill W; Lorenz B; Stôtzer O Anticancer Res; 1993; 13(5C):1809-14. PubMed ID: 7903521 [TBL] [Abstract][Full Text] [Related]
19. The disease with hope: hairy cell leukemia. Becker SE Clin J Oncol Nurs; 2007 Oct; 11(5):731-5. PubMed ID: 17962181 [TBL] [Abstract][Full Text] [Related]
20. [Successful ambulatory treatment of patients with hairy-cell leukemia using one cycle of the purine analog cladribine. 'Hemato-oncologic volwassen Nederland' (HOVON) Study Group]. Raemaekers JM; van 't Veer MB; Bogman MJ Ned Tijdschr Geneeskd; 1996 Aug; 140(31):1600-4. PubMed ID: 8768814 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]